Astrana Health, Inc.
HealthcareNASDAQ:ASTH · NASDAQ Capital Market
-$1.23 today
Vol 0.51M · Avg 0.46M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$3.5B of revenue converted into $30.2M of net income for the selected period. Gross margin is 9.5% and net margin is 0.9%, showing how much revenue survives after costs and taxes. EPS is $0.61, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.2B +56.4% | $2.0B +46.7% | $1.4B +21.2% | $1.1B +47.8% | $773.9M | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $2.9B +63.7% | $1.8B +50.5% | $1.2B +24.0% | $944.7M +58.5% | $596.1M | $725.6M | $804.0M | $882.4M |
| Gross Profit | $295.8M +9.0% | $271.4M +26.3% | $215.0M +7.8% | $199.5M +12.2% | $177.8M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 9.3% -4.0pp | 13.3% -2.2pp | 15.5% -1.9pp | 17.4% -5.5pp | 23.0% | 9.8% | 28.9% | 38.3% |
| Research & Development | $0 | $0 | $0 | $0 | $0 | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $217.3M +41.0% | $154.1M +36.9% | $112.6M +45.0% | $77.7M +25.1% | $62.1M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $217.3M +19.3% | $182.0M +39.7% | $130.3M +36.9% | $95.2M +19.6% | $79.6M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $45.7M +63.8% | $27.9M +57.4% | $17.7M +1.2% | $17.5M +0.1% | $17.5M | $374.2M | $1.2B | $631.8M |
| EBITDA | $135.3M -4.6% | $141.8M +14.7% | $123.7M +10.4% | $112.1M +11.3% | $100.7M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 4.3% -2.7pp | 7.0% -1.9pp | 8.9% -0.9pp | 9.8% -3.2pp | 13.0% | 5.6% | 46.3% | 42.0% |
| Operating Income | $78.5M -12.1% | $89.3M +5.6% | $84.6M -18.8% | $104.3M +6.2% | $98.2M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 2.5% -1.9pp | 4.4% -1.7pp | 6.1% -3.0pp | 9.1% -3.6pp | 12.7% | 16.6% | 24.1% | 22.0% |
| Interest Income | $12.2M -16.2% | $14.5M +2.1% | $14.2M +619.0% | $2.0M +25.8% | $1.6M | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $49.9M +50.9% | $33.1M +105.5% | $16.1M +103.3% | $7.9M +46.8% | $5.4M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$38.9M -356.2% | -$8.5M -263.3% | $5.2M +129.6% | -$17.6M +13.6% | -$20.4M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $39.6M -51.0% | $80.8M -10.0% | $89.8M +3.7% | $86.6M +11.4% | $77.7M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 1.2% -2.7pp | 4.0% -2.5pp | 6.5% -1.1pp | 7.6% -2.5pp | 10.0% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $15.5M -49.7% | $30.9M -3.4% | $32.0M -21.7% | $40.9M +29.0% | $31.7M | $1.3B | -$1.6B | $745.2M |
| Net Income | $22.5M -47.9% | $43.1M -28.9% | $60.7M +34.4% | $45.2M -34.5% | $68.9M | $4.9B | $4.8B | $4.7B |
| Net Margin | 0.7% -1.4pp | 2.1% -2.3pp | 4.4% +0.4pp | 3.9% -5.0pp | 8.9% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $0 -49.5% | $1 -30.0% | $1 +30.0% | $1 -36.3% | $2 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $0 -48.9% | $1 -30.2% | $1 +30.3% | $1 -34.9% | $2 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $49.1M +2.9% | $47.7M +2.1% | $46.7M +3.9% | $45.0M +2.6% | $43.8M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $49.4M +2.4% | $48.2M +2.5% | $47.1M +3.2% | $45.6M +0.4% | $45.4M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
LifeStance Health Group, Inc.
NASDAQ:LFST
$3.30B
National HealthCare Corporation
AMEX:NHC
$3.09B
Acadia Healthcare Company, Inc.
NASDAQ:ACHC
$2.26B
Select Medical Holdings Corporation
NYSE:SEM
$2.07B
Pediatrix Medical Group, Inc.
NYSE:MD
$2.00B
Omnicell, Inc.
NASDAQ:OMCL
$1.72B
Aveanna Healthcare Holdings Inc.
NASDAQ:AVAH
$1.54B
Healthcare Services Group, Inc.
NASDAQ:HCSG
$1.54B
MannKind Corporation
NASDAQ:MNKD
$1.13B
U.S. Physical Therapy, Inc.
NYSE:USPH
$997.74M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does ASTH generate?
Astrana Health, Inc. (ASTH) reported $3.18B of revenue in fiscal 2025.
Is ASTH profitable?
Astrana Health, Inc. (ASTH) reported $22.49M of net income, with a net margin of 0.7%.
Explore More
Continue the stock analysis
Jump to another research area for this company.